2 results match your criteria: "Respiratory and Inflammation Centre of Excellence for Drug Discovery[Affiliation]"
Drug Metab Dispos
October 2007
Drug Metabolism and Pharmacokinetics, Respiratory and Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, Stevenage, UK.
The pulmonary and hepatic expression and catalytic activities of phase I and II drug-metabolizing enzymes were compared using human lung and liver tissue, and lung parenchymal cells (LPCs) and cryopreserved hepatocytes. Cytochrome P450 gene expression was generally lower in lung than in liver and CYP3A4 expression in lung was negligible. Esterase gene expression was similar in lung and liver.
View Article and Find Full Text PDFSteroids
April 2005
Respiratory and Inflammation Centre of Excellence for Drug Discovery, GlaxoSmithKline, The Frythe, Welwyn, Herts AL6 9AR, UK.
Thymus involution is a useful marker of transactivation-mediated side effects in preclinical therapeutic index testing of new anti-inflammatory glucocorticosteroids, and is usually measured post mortem. We have validated the use of MRI for non-invasive in vivo measurement of mouse thymus involution induced by dexamethasone (DEX). Tl-weighted spin echo 7 T images provided satisfactory contrast between thymus and surrounding connective tissue and fat.
View Article and Find Full Text PDF